World
The round was co-led by investors including D. E. Shaw Ventures, ICONIQ, and MGX.
1
Seven key metrics that defined Grab’s first profitable year
2
Green Li-ion cuts losses by 44% in FY2025, eyes profitability in 2026
3
Japan Post Bank tops full-year alternative investment target by Q3
4
ByteDance in talks to sell gaming unit Moonton for over $6b
5
China says semiconductor supply chain stability top priority after Dutch ruling on Nexperia
More Stories
Singapore to roll out second tranche of $1.2-billion Anchor Fund
INA CEO Ridha Wirakusumah steps down
Viewpoint: Four venture trends poised to take shape in SE Asia in 2026
Mitsubishi-seeded PE firm AIGF raises $79m in first close of Fund III
India
With Fund II, W Health plans to build and scale 8-10 new companies over the next four years.
Singapore
The round was anchored by VC firm Gobi Partners.
The startup in focus helps manufacturers automate quality checks using AI.
Malaysia
The company has raised a total of nearly $6 million since inception.
Greater China
There was strong investor appetite for policy-aligned industries like software and semiconductor.
Existing investors, including Polaris Partners and SEEDS Capital, backed the round.
About 50% of the capital in its fourth fund has come from global LPs.
The capital proceeds will accelerate the clinical development of Ciraparantag.
The funding was led by Sofina and Sauce.vc.
